Seoul [South Korea], December 28 (ANI/Global Economic): 'Paxlovid,' the COVID-19 oral treatment developed by a global pharmaceutical company Pfizer, received emergency use authorization from the Ministry of Food and Drug Safety (MFDS) on the 27th. It is expected to be used from the end of Ja
.Washington [US], December 23 (ANI): The US Food and Drug Administration (FDA) on Wednesday (local time) authorized Pfizer's Paxlovid COVID-19 pill for high-risk people aged 12 and over to treat coronavirus disease (COVID-19).
Washington [US], December 15 (ANI): US President Joe Biden on Tuesday (local time) said that Pfizer's COVID-19 antiviral pill mark a significant step forward in the path out of the pandemic.
New York [US], November 5 (ANI): American pharmaceutical company Pfizer announced on Friday that its investigational COVID-19 oral antiviral candidate, Paxlovid, showed an 89 per cent reduction in hospitalisation or lethal cases in high-risk patients.